BCM
DERM

Bayesian Capital Management’s Dermira, Inc. DERM Stock Holding History

Bayesian Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,700
Closed -$75K – 816
2019
Q3 		$75K Buy
+11,700
New +$97.7K 0.01% 483
2016
Q3 		– Sell
-7,900
Closed -$231K – 571
2016
Q2 		$231K Buy
+7,900
New +$218K 0.14% 289

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayesian Capital Management's DERM Position: Q4 2019 in Review

Bayesian Capital Management sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 11,700 shares — an estimated $75K sold.

Bayesian Capital Management first reported a position in DERM in Q2 2016 and held it in 2 quarters. The position peaked at $231K in Q2 2016. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

  • Bayesian Capital Management reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 11,700 Dermira, Inc. shares in Q4 2019, an estimated $75K.
  • Bayesian Capital Management first reported a position in Dermira, Inc. in Q2 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Dermira, Inc. position peaked at $231K in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.